Related Experiment Video
Updated: Aug 2, 2025
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Is Gastrointestinal Bleeding a Problem for COVID-19 Intensive Care Unit Patients?
Alessandra Negro1,2,3,4,5,6,7,8, Giulia Villa1,2,3,4,5,6,7,8, Matteo Cardinali1,2,3,4,5,6,7,8
1Alessandra Negro, RN, is Nursing, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Gastrointestinal bleeding occurred in 13.8% of critically ill COVID-19 patients. Solid tumors and liver disease increased this risk, necessitating individualized care for high-risk individuals.
Area of Science:
- Critical Care Medicine
- Gastroenterology
- Infectious Diseases
Background:
- COVID-19 critically ill patients present unique challenges.
- Gastrointestinal bleeding (GIB) is a potential complication in intensive care unit (ICU) settings.
Purpose of the Study:
- To describe the characteristics and outcomes of COVID-19 patients experiencing gastrointestinal bleeding in the ICU.
- To identify risk factors associated with GIB in this population.
Main Methods:
- Observational prospective study adhering to STROBE checklist.
- Inclusion of all patients admitted to the ICU between February and April 2020.
- Analysis of sociodemographic data, clinical history, gastrointestinal symptoms, and outcomes.
Main Results:
- 16 out of 116 (13.8%) COVID-19 patients developed GIB.
- GIB patients were predominantly male (93.7%), median age 65.64 years, and all required mechanical ventilation.
- Comorbidities, particularly solid tumors and chronic liver disease, were significant risk factors (p<0.05).
Conclusions:
- Gastrointestinal bleeding is a notable complication in critically ill COVID-19 patients.
- The presence of solid tumors or chronic liver disease increases the risk of GIB.
- Healthcare providers should identify and monitor high-risk COVID-19 patients for GIB to enhance safety.
More Related Videos
07:16An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
Published on: November 30, 2022
14:28Non-Invasive Monitoring of Microvascular Oxygenation and Reactive Hyperemia using Hybrid, Near-Infrared Diffuse Optical Spectroscopy for Critical Care
Published on: May 10, 2024
Related Concept Videos
01:28Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:28Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
01:23Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD: